Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 30, 2015 2:17 AM ET


Company Overview of Aclaris Therapeutics, Inc.

Executive Profile

Neal Walker D.O.

Chief Executive Officer, President and Director, Aclaris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Neal Walker, D.O., founded Aclaris Therapeutics, Inc. in 2012 and also has been its Chief Executive Officer and President since July 2012. Dr. Walker is also Co-Founding Member and Partner of NeXeption, LLC. He co-founded Octagon Research Solutions, Inc. in 1999. He co-founded Vicept Therapeutics, Inc. and served as its Chief Executive Officer, President and Director from 2009 to 2012. He has over 16 years of pharmaceutical industry experience in R&D, regulatory ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 484-324-7933
Fax: 484-320-2344

Board Members Memberships

Vice Chairman
Chief Executive Officer, President and Director
Director and Member of Audit Committee


Lehigh University
Unknown/Other Education
Philadelphia College Of Osteopathic Medicine
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

Total Annual Compensation$339,900

Stocks Options

All Other Compensation$10,400
Unexercisable Options$560,243
Total Number of Options$560,243

Total Compensation

Total Annual Cash Compensation$452,270
Total Short Term Compensation$339,900
Other Long Term Compensation$10,400
Total Calculated Compensation$693,690

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aclaris Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at